Between hyperfiltration and impairment: Demystifying early renal functional changes in diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 1, 2008, Pages

  Rosolowsky, Elizabeth T ^a,b   Niewczas, Monika A ^a,c,e   Ficociello, Linda H ^a   Perkins, Bruce A ^d   Warram, James H ^a   Krolewski, Andrzej S ^a,c  

^a JOSLIN DIABETES CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cystatin C; Early renal function decline; Microalbuminuria; Type 1 Diabetes

Indexed keywords

ALBUMIN; CYSTATIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; URIC ACID;

ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MICROALBUMINURIA; PROTEINURIA; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

ALBUMINURIA; CYSTATINS; CYTOKINES; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; PROTEINURIA; URIC ACID;

EID: 55249119725     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.018     Document Type: Article

References (54)

1. Andersen A., Christiansen J., Andersen J., Kreiner S., and Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25 (1983) 496-501
2. Krolewski A., Warram J., Christlieb A., Busick E., and Kahn C. The changing natural history of nephropathy in type 1 diabetes. Am. J. Med. 78 (1989) 785-794
3. Krolewski M., Eggers P., and Warram J. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int. 50 (1996) 2041-2046
4. U.S. Renal Data System, USRDS 2007 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2007.
5. Mogensen C. Renal function changes in diabetes. Diabetes 25 (1976) 872-879
6. Keen H., and Chlouverakis C. An immunoassay method for urinary albumin at low concentrations. Lancet 2 (1963) 913-916
7. Viberti G., Hill R., Jarrett R., Argyropoulos, Mahmud U., and Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1 (1982) 1430-1432
8. Parving H., Oxenboll B., Svendsen P., Christiansen J., and Andersen A. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol. 100 (1982) 550-555
9. Mogensen C., and Christensen C. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311 (1984) 89-93
10. Mogensen C., Chachati A., Christensen C., Close C., Deckert T., Hommel E., et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 9 (1985-1986) 85-95
11. Christiansen J., Gammelgaard J., Frandsen M., and Parving H. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 20 (1981) 451-456
12. Rudberg S., Persson B., and Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy-an 8-year prospective study. Kidney Int. 41 (1992) 822-828
13. Hansen K., Mau Pedersen M., Christensen C., Schmitz A., Mogensen C., and Christensen J. Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J. Intern. Med. 232 (1992) 161-167
14. Hostetter T., Troy J., and Brenner B. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 19 (1981) 410-415
15. Vallon V., Blantz R., and Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J. Am. Soc. Nephrol. 14 (2003) 530-537
16. Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int. 40 (1991) 792-807
17. Zatz R., and Brenner B. Pathogenesis of diabetic microangiopathy: the hemodynamic view. Am. J. Med. 80 (1986) 443-453
18. Lervang H., Jensen S., Brochner-Mortensen J., and Ditzel J. Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31 (1988) 723-729
19. Jensen T., Borch-Johnsen K., and Deckert T. Changes in blood pressure and renal function in patients with type 1 (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy. Diabetes Res. 4 (1987) 159-162
20. Mogensen C. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 31 (1987) 673-689
21. Feldt-Rasmussen B., Mathiesen E., and Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 2 (1986) 1300-1304
22. Christensen C., and Mogensen C. Effect of antihypertensive treatment on progression of disease in incipient diabetic nephropathy. Hypertension 7 (1985) 109-114
23. The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann. Intern. Med. 134 (2001) 370-379
24. Perkins B., Ficociello L., Silva K., Finkelstein D., Warram J., and Krolewski A. Regression of microalbuminuria in type 1 diabetes. N. Engl. J. Med. 348 (2003) 2285-2293
25. Giorgino F., Laviola L., Cavallo Perin P., Solnica B., Fuller J., and Chaturvedi N. Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetololgia 47 (2004) 1020-1028
26. Chavers B., Bilous R., Ellis E., Steffes M., and Mauer S. Glomerular lesions and urinary albumin excretion in type 1 diabetes without overt proteinuria. N. Engl. J. Med. 13 (1989) 966-970
27. Fioretto P., Steffes M., and Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43 (1994) 1358-1364
28. Rule A. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 16 (2007) 242-249
29. Grubb A., and Lofberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 3024-3027
30. Vinge E., Lindergard B., Nilsson-Ehle P., and Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand. J. Clin. Lab. Invest. 59 (1999) 587-592
31. Tan G., Lewis A., James T., Altmann P., Taylor R.P., and Levy J. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25 (2002) 2004-2009
32. Perkins B., Nelson R., Ostrander B., Blouch K., Krolewski A., Myers B., et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J. Am. Soc. Nephrol. 16 (2005) 1404-1412
33. MacIsaac R., Tsalamandris C., Thomas M., Premaratne E., Panagiotopoulos S., Smith T., et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 49 (2006) 1686-1689
34. Premaratne E., MacIsaac R., Finch S., Panagiotopoulos S., Ekinci E., and Jerums G. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 31 (2008) 971-973
35. Perkins B., Ficociello L., Ostrander B., Silva K., Weinberg J., Warram J., et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J. Am. Soc. Nephrol. 18 (2007) 1353-1361
36. Lindeman R., Tobin J., and Shock N. Longitudinal studies on the rate of decline in renal function with age. J. Am. Geriatr. Soc. 33 (1985) 278-285
37. Perkins B., Ficociello L., Roshan B., Warram J., and Krolewski A. Decline in renal function to end stage renal disease begins soon after the onset of microalbuminuria (MA) in Type 1 Diabetes (T1DM): results of 12-year follow-up. J. Am. Soc. Nephrol. 18 (2007) 44A
38. Rosolowsky E., Ficociello L., Maselli N., Niewczas M., Binns A., Roshan B., et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin. J. Am. Soc. Nephrol. 3 (2008) 706-713
39. Tseng C.H. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int. 68 (2005) 796-801
40. Bo S., Cavallo-Perin P., Gentile L., Repetti E., and Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur. J. Clin. Invest. 31 (2001) 318-321
41. Iseki K., Oshiro S., Tozawa M., Iseki C., Ikemiya Y., and Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens. Res. 24 (2001) 691-697
42. Johnson R., Kang D., Feig D., Kivlighn S., Kanellis J., Watanabe S., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 41 (2003) 1183-1190
43. Kang D., Nakagawa T., Feng L., Watanabe S., Han L., Mazzali M., et al. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 13 (2002) 2888-2897
44. Kang D., Park S., Lee I., and Johnson R. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol. 16 (2005) 3553-3562
45. Perlstein T., Gumieniak O., Hopkins P., Murphey L., Brown N., Williams G., et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 66 (2004) 1465-1470
46. Pillinger M., Rosenthal P., and Abeles A. Hyperuricemia and gout: new insights into pathogenesis and treatment. Bull. NYU Hosp. Jt. Dis. 65 (2007) 215-221
47. M. Niewczas, L. Ficociello, A. Johnson, W. Walker, E. Rosolowsky, B. Roshan, et al. Serum concentrations of markers of TNFa and Fas-mediated pathways and renal function in non-proteinuric patients with type 1 diabetes. Clin. J. Am. Soc. Nephrol. 2008 (in press).
48. Navarro J., and Mora-Fernandez C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev. 17 (2006) 441-450
49. Galkina E., and Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J. Am. Soc. Nephrol. 17 (2006) 368-377
50. Mazzali M., Kanellis J., Han L., Feng L., Xia Y.-Y., Chen Q., et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am. J. Physiol. Renal Physiol. 282 (2002) F991-F997
51. Kumar D., Zimpelmann J., Robertson S., and Burns K. Tubular and interstitial cell apoptosis in the streptozotocin-diabetic rat kidney. Nephron. Exp. Nephrol. 96 (2004) e77-88
52. Kumar D., Robertson S., and Burns K. Evidence of apoptosis in human diabetic kidney. Mol. Cell Biochem. 259 (2004) 67-70
53. Kang D., Kanellis J., Hugo C., Truong L., Anderson S., Kerjaschki D., et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13 (2002) 806-816
54. Siu Y., Leung K., Tong M., and Kwan T. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am. J. Kidney Dis. 47 (2006) 51-59